Celgene, Novartis File Suit Against Generic Ritalin
Pharmaceutical companies Celgene Corp. and Novartis AG have filed a patent infringement suit against generics maker Abrika Pharmaceuticals Inc. over a time-release version of Ritalin, a drug used to treat attention...To view the full article, register now.
Already a subscriber? Click here to view full article